Table 3 Cox regression—overall survival.
 | Univariate | Multivariable | ||||
---|---|---|---|---|---|---|
Hazard ratio | 95% CI | p-value | Hazard ratio | 95% CI | p-value | |
Gender | ||||||
Female | Reference | Reference | Â | Reference | Reference | Â |
Male | 1.44 | (1.01–2.06) | 0.046* | 0.75 | (0.52–1.09) | 0.135 |
Age | 1.03 | (1.02–1.05) |  < 0.001** | 1.04 | (1.02–1.06) |  < 0.001** |
GNRI | ||||||
 ≥ 92 | Reference | Reference |  | Reference | Reference |  |
 < 92 | 4.47 | (3.10–6.43) |  < 0.001** | 3.94 | (2.70–5.74) | < 0.001** |
Performance status ECOG | ||||||
0 | Reference | Reference | Â | Â | Â | Â |
1 | 0.73 | (0.44–1.20) | 0.209 |  |  |  |
2–4 | 1.43 | (0.82–2.51) | 0.209 |  |  |  |
Comorbidity | ||||||
HTN | 1.09 | (0.75–1.58) | 0.647 |  |  |  |
DM | 1.57 | (1.05–2.33) | 0.027* | 0.92 | (0.60–1.41) | 0.699 |
COPD/asthema | 1.75 | (0.72–4.30) | 0.220 |  |  |  |
CAD | 1.89 | (0.92–3.87) | 0.082 |  |  |  |
Creatinine > 1.5 mg/dL | 1.38 | (0.94–2.05) | 0.104 |  |  |  |
Smoking status | ||||||
Never | Reference | Reference | Â | Â | Â | Â |
Current/former | 1.39 | (0.95–2.03) | 0.094 |  |  |  |
Preoperative renal function | ||||||
eGFR ≥ 30 ml/min/1.73m2 | Reference | Reference |  |  |  |  |
eGFR < 30 ml/min/1.73m2 | 1.42 | (0.96–2.10) | 0.077 |  |  |  |
History of uremia | ||||||
Negative | Reference | Reference | Â | Â | Â | Â |
Positive | 1.19 | (0.73–1.92) | 0.487 |  |  |  |
Surgical margin | ||||||
Negative | Reference | Reference | Â | Reference | Reference | Â |
Positive | 4.62 | (3.05–7.02) | < 0.001** | 1.78 | (1.13–2.82) | 0.013* |
Pathological T | ||||||
T1 | Reference | Reference | Â | Reference | Reference | Â |
T2 | 2.33 | (1.20–4.52) | 0.013* | 1.51 | (0.77–2.99) | 0.232 |
T3 | 4.19 | (2.64–6.64) | < 0.001** | 2.54 | (1.53–4.21) |  < 0.001** |
T4 | 18.21 | (10.43–31.79) | < 0.001** | 6.75 | (3.17–14.37) |  < 0.001** |
Pathological N | ||||||
N0 | Reference | Reference | Â | Reference | Reference | Â |
N1 | 3.15 | (1.53–6.50) | 0.002** | 1.23 | (0.57–2.63) | 0.597 |
N2–3 | 6.27 | (3.84–10.22) | < 0.001** | 1.08 | (0.56–2.09) | 0.811 |
Tumor grade | ||||||
Low | Reference | Reference | Â | Reference | Reference | Â |
High | 15.65 | (2.18–112.03) | 0.006** | 7.22 | (0.99–52.96) | 0.052 |
Lymphovascular invasion | ||||||
Negative | Reference | Reference | Â | Reference | Reference | Â |
Positive | 4.39 | (3.06–6.31) |  < 0.001** | 1.81 | (1.16–2.81) | 0.008** |